Stockreport

Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19 [Yahoo! Finance]

Taysha Gene Therapies, Inc.  (TSHA) 
PDF focused on developing and commercializing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system (CNS), today announced th [Read more]